LivaNova PLC

NASDAQ:LIVN

Medical - Devices

Healthcare
$94.54 +0.96%

+$0.76 today

Market cap
$5.21B
Beta
0.88
P/E (TTM)
40.5
EPS (TTM)
$1.96
52W Low $41.02High $80.96

Volume 1.32M

Average 0.79M

LIVN Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

LivaNova PLCNASDAQ: LIVN

Selling, General & Admin · Q3 FY2026 · quarter ended Sep 2026

Selling, general & admin grows in line with its trailing trend

Q3 FY2026 selling, general & admin of $154.9M rose 11.8% year over year, ahead of the +10.0% change in trailing-twelve-month selling, general & admin. Sequentially, it fell 2.0% from the prior quarter. Over 3 fiscal years it compounded at +5.4% a year.

Context

  • Selling, general & admin amounted to 39.5% of revenue in FY2025, down 2.4 pp from a year earlier.
  • Selling, general & admin increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether selling, general & admin reaches the consensus estimate from 8 analysts of $668.75M (+21.9%) for the fiscal year ending Dec 2026, a step up from the +4.3% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
$154.9M-2.0% QoQ
Last fiscal yearDec 2025
$548.8M+4.3% YoY
LTMSep 2026
$599.94M+10.0% YoY
Selling, General & Admin past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+11.8%+18.3%+6.5 pp
1 year+4.3%+21.9%+17.6 pp
3-year CAGR+5.4%+12.0%+6.6 pp
5-year CAGR+12.8%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Selling, General & Admin history

USD · from the income statement

Latest · FY2025
548.8M USD
Year-over-year change
+4.3%
4-year CAGR
+3.8%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Selling, General & Admin vs competitors

How LIVN compares with its peers on the latest reported figures

  • LIVN's LTM Sep 2026 selling, general & admin of $599.94M is the 6th highest of the 10 companies compared; the peer median is $620.31M.
  • Its year-over-year change of +10.0% is the 8th highest of 10, against a peer median of +12.4%.
  • Selling, general & admin amounts to 39.8% of revenue for LIVN, versus a peer median of 34.1%.
LIVN Competitors Peer median
Selling, General & Admin for LIVN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$12.18B +10.7%+4.2%32.4%
BSXBoston Scientific CorporationLTM Jun 2026$7.16B +10.4%+15.1%34.1%
EWEdwards Lifesciences CorporationLTM Jun 2026$2.2B +17.0%+10.0%33.8%
RMDResMed Inc.LTM Jun 2026$1.11B +12.4%+8.6%19.7%
INSPInspire Medical Systems, Inc.LTM Jun 2026$620.31M +7.7%+24.9%69.0%
LIVNLivaNova PLCLTM Sep 2026$599.94M +10.0%+5.4%39.8%
HAEHaemonetics CorporationLTM Jun 2026$449.95M +293.0%+5.8%33.3%
STIMNeuronetics, Inc.LTM Mar 2026$95.81M +14.8%+8.8%63.2%
CVRXCVRx, Inc.LTM Mar 2026$88.81M +5.3%+20.9%150.3%
NPCENeuroPace, Inc.LTM Mar 2026$67.05M +17.5%+8.6%67.4%
MOBIMobia Medical, Inc. Common Stock—— ———
Peer median (excluding LIVN) $620.31M+12.4%+8.8%34.1%

Competitors are the stored peer set for LIVN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.04B1.02B1.15B1.25B1.39B
Cost of Revenue329.37M314.58M382.3M382.56M448.2M
Gross Profit705.99M707.23M771.25M870.87M939.9M
Gross Margin68.2%69.2%66.9%69.5%67.7%
Research & Development183.41M155.81M193.82M182.51M185.8M
Selling, General & Admin471.9M469.24M518.13M526.27M548.8M
Operating Expenses706.78M783.98M839.75M741.82M740.5M
Depreciation & Amortization67.99M57.8M60.86M51.14M42M
EBITDA(6.33M)30.9M38.48M202.52M(129.5M)
EBITDA Margin-0.6%3.0%3.3%16.2%-9.3%
Operating Income(784K)(76.75M)(68.5M)129.05M199.4M
Operating Margin-0.1%-7.5%-5.9%10.3%14.4%
Interest Income435K4.7M22.01M30.08M18.98M
Interest Expense50.15M48.25M58.85M63.07M49.29M
Other Income / Expenses(123.84M)1.56M(12.83M)(40.74M)(420.2M)
Income Before Tax(124.62M)(75.2M)(81.33M)88.31M(220.8M)
Pre-Tax Margin-12.0%-7.4%-7.1%7.0%-15.9%
Income Tax Expense11.2M11.05M(98.88M)25.06M21.6M
Net Income(135.82M)(86.25M)17.55M63.23M(242.5M)
Net Margin-13.1%-8.4%1.5%5.0%-17.5%
EPS (Basic)(2.68)(1.61)0.331.17(4.45)
EPS (Diluted)(2.68)(1.61)0.321.16(4.45)
Weighted Avg Shares50.63M53.5M53.9M54.24M54.5M
Weighted Avg Shares (Diluted)50.63M53.5M54.21M54.57M54.5M

LivaNova PLC

NASDAQ:LIVN

Intrinsic Alpha fair value

Locked

Current Price

$94.54

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.